Jeudi du PSCC #19 : In vivo CAR

We are pleased to welcome three outstanding speakers bringing complementary perspectives from research, industry and investment: · Silvia Menegatti, Head of R&D, CellAction / Institut Curie · Christopher Borges, Head of Non-Viral Gene Therapy and Genome Engineering, Sanofi · Sofia Arnal, AdBio partners Together, they will explore the opportunities and challenges shaping in vivo CAR approaches, from scientific innovation and translational development to industrial and investment perspectives.